Ultrasensitive immunoassay of breast cancer type 1 susceptibility protein (BRCA1) using poly (dopamine-beta cyclodextrine-Cetyl trimethylammonium bromide) doped with silver nanoparticles: A new platform in early stage diagnosis of breast cancer and efficient management
Ultrasensitive immunoassay of breast cancer type 1 susceptibility protein (BRCA1) using poly (dopamine-beta cyclodextrine-Cetyl trimethylammonium bromide) doped with silver nanoparticles: A new platform in early stage diagnosis of breast cancer and efficient management
نویسندگان: محمد حسن زاده محله , امیر علی مختارزاده , ابوالقاسم جویبان , جعفر سلیمانی
کلمات کلیدی: Biomedical analysis, Tumor protein BRCA1, Immunoassay, Breast cancer, Immunocomplex, Polymer
نشریه: 24084 , 01 , 145 , 2019
| نویسنده ثبت کننده مقاله |
محمد حسن زاده محله |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات کاربردی دارویی |
| کد مقاله |
65184 |
| عنوان فارسی مقاله |
Ultrasensitive immunoassay of breast cancer type 1 susceptibility protein (BRCA1) using poly (dopamine-beta cyclodextrine-Cetyl trimethylammonium bromide) doped with silver nanoparticles: A new platform in early stage diagnosis of breast cancer and efficient management |
| عنوان لاتین مقاله |
Ultrasensitive immunoassay of breast cancer type 1 susceptibility protein (BRCA1) using poly (dopamine-beta cyclodextrine-Cetyl trimethylammonium bromide) doped with silver nanoparticles: A new platform in early stage diagnosis of breast cancer and efficient management |
| ناشر |
8 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
خیر |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Breast cancer type 1 susceptibility protein (BRCA1) is antioncogenes in women, who are genetically predisposed to breast cancer. Therefore, development of a reliable method for sensitive and selective detection of BRCA1 with low concentration level is very important. In this research work a novel immunoassay based on signal amplification strategy of multiple polymers to recognition of BRCA1 protein was developed. The engineered immunoassay prepared by poly (dopamine-beta cyclodextrine-Cetyl trimethylammonium bromide doped by silver nanoparticles (P[DA-β-CD/CTAB])-AgNPs) and functionalized mesoporous silica (MCM-41-SO3H) composite fabricated on the glassy carbon electrode with a large surface area which was prepared a new platform to immobilization of primary antibodies and provide excellent conductivity. To further amplify the electrochemical signal, MCM-41-SO3H provides suitable pores volume and functional groups to capture more horseradish peroxidase-labeled antibodies (HPR-Ab2) and enhances the conductivity. The proposed immunoassay displays suitable analytical performance for the monitoring of BRCA1 with a linear range from 0.01565–10 pg/mL (by DPV) and 0.625–20 pg/mL (by SWV) and a low limit of quantification of 0.003 pg/mL. Also, satisfactory results are obtained for the determination of BRCA1 in human plasma samples and MCF-7 cancer cell lysates, indicating the potential of the immunoassay to be applied in clinical analysis. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| 169.pdf | 1397/09/10 | 646201 | دانلود |